This study is testing the effect of etanercept in treating both the skin and joint symptoms
of psoriatic arthritis patients. Enbrel®, also known as etanercept, has already been approved
by the Federal Food Drug Administration for the treatment of psoriatic arthritis. It is taken
as an injection under the skin. Participants in the trial will be offered etanercept free of
charge to be self-injected once weekly for 24 weeks. During that period they will have 5
appointments at the study center and will also be asked to complete assessments of their
health.